Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
781.10 | -49.46% | -28.72% | 703,588.4 | 0.71% | 2.63% |
|
NYSE:ABBV
AbbVie
|
162.64 | -21.26% | -10.86% | 287,978.03 | 3.84% | 7.03% |
|
LSE:AZN
AstraZeneca PLC
|
120.62 | 19.39% | 42.19% | 186,988.87 | 2.05% | 15.98% |
|
NYSE:PFE
Pfizer
|
25.62 | 21.3% | 55.25% | 145,074.31 | 6.55% | -9.31% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
14.05 | -37.63% | -33.61% | 15,913.6 | 0% | -4.66% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.57 | 1.95% | 12.16% | 13,740.18 | 4.07% | -8.55% |
|
CPSE:HLUN A
H. Lundbeck A/S
|
34.04 | 96.51% | 123.29% | 32,856.1 | 2.1% | 32.92% |
|
NasdaqGS:ALKS
Alkermes
|
24.54 | 175.95% | 200.99% | 4,151.78 | 0% | 18.74% |
|
LSE:INDV
Indivior PLC
|
14.42 | -23.61% | -1.68% | 1,952.43 | 0% | -2.7% |
|
NasdaqGM:VNDA
Vanda Pharmaceuticals
|
4.76 | 0% | 0% | 277.02 | 0% | -8.62% |
